Cher Wins Sonny Bono Royalty Battle: Fees Still Up to You
A high-profile royalty dispute shows that winning rights doesn’t always cover legal bills. This article breaks down w...
Which Index Fund Is Best After Rolling Over An Ira
Compare which index fund is best after rolling over an IRA by examining expense ratios, tracking error, and portfolio breadth to support retirement goals.
27,882 articles
Retiree Health Coverage From Sparks Medicare Penalties
A 67-year-old retiree faces a permanent Medicare surcharge after enrolling late, despite rich retiree health coverage...
Entravision (EVC) 2025 Earnings: Trends, Risks, and Outlook
What could drive Entravision's 2025 earnings, and what should investors watch next? This guide breaks down the driver...
Tuniu (Tour) 2026 Earnings: Investor Outlook for Investors
Tuniu faces a shifting travel landscape as 2026 unfolds. This guide breaks down what to watch in tuniu (tour) 2026 ea...
Three-Time Olympic Canoeist Pleads Guilty Over Pool Incident
A court in Washington, D.C. heard a not-guilty plea from a prominent Olympic athlete tied to damage at the Reflecting...
Coda Octopus (CODA) 2026 Earnings Outlook for Investors
When CODA reports its Q2 2026 results, the focus shifts from headlines to signals—backlog, margins, and customer wins...
Intel Rallied Today: Key Drivers Behind the Move in Stocks
Investors woke up to a modest rally in Intel as executives highlighted strong demand and expansion plans. This articl...
This Biotech with Breakout MS Drug Draws Big Investment
A breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
Carvana Price Target Adjusted to $93 as Retail Volumes Hold
Barclays lowers Carvana's price target to $93 after a 5-for-1 stock split, while reaffirming an overweight stance as ...
NVIDIA Gets Tepid Market Reaction, Boosts Share Rewards
NVIDIA guided higher-than-expected revenue for the coming quarter, but investors greeted the news with a muted respon...
Viking Therapeutics Stock No-Brainer: Is It Worth Buying Below $35?
Viking Therapeutics trades around the low $30s as pivotal data for VK2735 approaches. This article breaks down whethe...
Office Conversions Face Scrutiny After Pfizer HQ Incident
A buckling-column episode at the former Pfizer headquarters triggers renewed scrutiny of NYC office-to-residential pr...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status